Michel Pieren

968 total citations
18 papers, 736 citations indexed

About

Michel Pieren is a scholar working on Molecular Biology, Molecular Medicine and Cell Biology. According to data from OpenAlex, Michel Pieren has authored 18 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Molecular Medicine and 5 papers in Cell Biology. Recurrent topics in Michel Pieren's work include Antibiotic Resistance in Bacteria (7 papers), Vibrio bacteria research studies (3 papers) and Tuberculosis Research and Epidemiology (2 papers). Michel Pieren is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Vibrio bacteria research studies (3 papers) and Tuberculosis Research and Epidemiology (2 papers). Michel Pieren collaborates with scholars based in Switzerland, United Kingdom and United States. Michel Pieren's co-authors include Carmela Galli, Maurizio Molinari, Paolo Paganetti, Marcel Tigges, Andrea Schmidt, Andreas Mayer, Kurt Ballmer‐Hofer, C. Manlius, Augustyn Bogucki and Luca Cariolato and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Nature Reviews Drug Discovery.

In The Last Decade

Michel Pieren

18 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Pieren Switzerland 11 439 278 157 111 71 18 736
Jungki Min United States 13 391 0.9× 166 0.6× 109 0.7× 29 0.3× 95 1.3× 21 760
Laurence Vandel France 18 892 2.0× 45 0.2× 139 0.9× 49 0.4× 53 0.7× 28 1.1k
John A. Buglino United States 14 762 1.7× 75 0.3× 32 0.2× 100 0.9× 23 0.3× 18 986
Sunil K. Sukumaran Singapore 11 339 0.8× 76 0.3× 21 0.1× 71 0.6× 62 0.9× 15 573
Marie Pénary France 15 471 1.1× 46 0.2× 67 0.4× 58 0.5× 149 2.1× 22 770
Chuanling Zhang China 17 435 1.0× 32 0.1× 62 0.4× 95 0.9× 56 0.8× 26 691
Fabrice Bouillenne Belgium 14 290 0.7× 23 0.1× 190 1.2× 65 0.6× 50 0.7× 25 553
Hyoun Sook Kim South Korea 17 486 1.1× 42 0.2× 37 0.2× 72 0.6× 31 0.4× 49 736
Chiara Lucchetti Italy 13 259 0.6× 23 0.1× 116 0.7× 46 0.4× 49 0.7× 20 540
Gun Wook Park South Korea 15 715 1.6× 56 0.2× 25 0.2× 124 1.1× 54 0.8× 27 1.0k

Countries citing papers authored by Michel Pieren

Since Specialization
Citations

This map shows the geographic impact of Michel Pieren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Pieren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Pieren more than expected).

Fields of papers citing papers by Michel Pieren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Pieren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Pieren. The network helps show where Michel Pieren may publish in the future.

Co-authorship network of co-authors of Michel Pieren

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Pieren. A scholar is included among the top collaborators of Michel Pieren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Pieren. Michel Pieren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Terlouw, Barbara R., Chao Du, Joost Willemse, et al.. (2024). Discovery and Derivatization of Tridecaptin Antibiotics with Altered Host Specificity and Enhanced Bioactivity. ACS Chemical Biology. 19(5). 1106–1115. 3 indexed citations
3.
Couet, William, Sophie Lagrange, Meindert H. Lamers, et al.. (2024). The AMR Accelerator: from individual organizations to efficient antibiotic development partnerships. Nature Reviews Drug Discovery. 24(1). 1–2. 2 indexed citations
4.
Pieren, Michel, Marc Gitzinger, Maria Santos Martínez, et al.. (2024). First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drug. Journal of Antimicrobial Chemotherapy. 79(6). 1353–1361. 2 indexed citations
5.
Janssen, Axel B., Vincent de Bakker, Rieza Aprianto, et al.. (2023). Klebsiella pneumoniae OmpR facilitates lung infection through transcriptional regulation of key virulence factors. Microbiology Spectrum. 12(1). e0396623–e0396623. 2 indexed citations
6.
Trebosc, Vincent, Mohit Narwal, Marilyne Bourotte, et al.. (2022). Targeting virulence regulation to disarm Acinetobacter baumannii pathogenesis. Virulence. 13(1). 1868–1883. 7 indexed citations
7.
Sivignon, Adeline, Michel Pieren, Marc Gitzinger, et al.. (2021). The Role of OmpR in Bile Tolerance and Pathogenesis of Adherent-Invasive Escherichia coli. Frontiers in Microbiology. 12. 684473–684473. 12 indexed citations
8.
Trebosc, Vincent, Marcus Tötzl, Michel Pieren, et al.. (2019). Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates. mBio. 10(4). 94 indexed citations
9.
Zischinsky, Gunther, Michel Pieren, Kenny Bravo‐Rodriguez, et al.. (2019). Chemical Validation of DegS As a Target for the Development of Antibiotics with a Novel Mode of Action. ChemMedChem. 14(11). 1074–1078. 13 indexed citations
10.
Trebosc, Vincent, Pablo Manfredi, Marcus Tötzl, et al.. (2016). A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism. Antimicrobial Agents and Chemotherapy. 60(12). 7263–7271. 34 indexed citations
11.
Pieren, Michel, et al.. (2015). Vacuolar SNARE Protein Transmembrane Domains Serve as Nonspecific Membrane Anchors with Unequal Roles in Lipid Mixing. Journal of Biological Chemistry. 290(20). 12821–12832. 22 indexed citations
12.
Pieren, Michel & Marcel Tigges. (2012). Adjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistance. Current Opinion in Pharmacology. 12(5). 551–555. 49 indexed citations
13.
Pieren, Michel, Andrea Schmidt, & Andreas Mayer. (2010). The SM protein Vps33 and the t-SNARE Habc domain promote fusion pore opening. Nature Structural & Molecular Biology. 17(6). 710–717. 56 indexed citations
14.
Suarez, Stéphanie, Michel Pieren, Luca Cariolato, et al.. (2006). A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2. Cellular and Molecular Life Sciences. 63(17). 2067–2077. 161 indexed citations
15.
Pieren, Michel, A.E. Prota, Dirk Kostrewa, et al.. (2006). Crystal Structure of the Orf Virus NZ2 Variant of Vascular Endothelial Growth Factor-E. Journal of Biological Chemistry. 281(28). 19578–19587. 28 indexed citations
16.
Wagner, Armin, Michel Pieren, Clemens Schulze‐Briese, Kurt Ballmer‐Hofer, & A.E. Prota. (2006). Structure determination of VEGF-E by sulfur SAD. Acta Crystallographica Section D Biological Crystallography. 62(11). 1430–1434. 8 indexed citations
17.
Pieren, Michel, Carmela Galli, Angela Denzel, & Maurizio Molinari. (2005). The Use of Calnexin and Calreticulin by Cellular and Viral Glycoproteins. Journal of Biological Chemistry. 280(31). 28265–28271. 57 indexed citations
18.
Molinari, Maurizio, et al.. (2002). Sequential assistance of molecular chaperones and transient formation of covalent complexes during protein degradation from the ER. The Journal of Cell Biology. 158(2). 247–257. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026